Economic Impact of Integrated Behavioral Health


Medical costs for treating those patients with chronic medical and comorbid mental health/substance use disorder (MH/SUD) conditions are two to three times higher on average compared to the costs for those beneficiaries who don’t have comorbid MH/SUD conditions. The projected additional healthcare costs incurred by people with behavioral comorbidities are estimated to be $406 billion in 2017 across commercially insured, Medicaid, and Medicare beneficiaries in the United States.